Summary of Key Points Core Viewpoint - The Hong Kong Stock Exchange (HKEX) has seen significant activity in the IPO market, with 11 companies submitting applications, 8 passing hearings, and 3 new stocks listed during the week of June 9 to June 15, 2025 [1]. Group 1: Companies Submitting Applications - Guangzhou Yinnuo Pharmaceutical Group Co., Ltd. focuses on diabetes and metabolic diseases, with a core product expected to receive regulatory approval in January 2025. The company reported losses of RMB 733 million and RMB 175 million for 2023 and 2024, respectively [2]. - Shenzhen Chuangzhi Xilian Technology Co., Ltd. is a leading provider of metallization interconnection coating materials, with projected revenues of approximately RMB 3.2 billion, RMB 3.12 billion, and RMB 4.1 billion from 2022 to 2024 [3][4]. - Minglue Technology is a top data intelligence application software company in China, with revenues of RMB 12.69 billion, RMB 14.62 billion, and RMB 13.81 billion from 2022 to 2024 [5]. - Guangdong Dongyangguang Pharmaceutical Co., Ltd. specializes in drug development and commercialization, reporting revenues of approximately RMB 38.14 billion and RMB 63.86 billion for 2023 and 2024, respectively [6]. - Guangzhou Guanghe Technology Co., Ltd. is a leading manufacturer of PCB for computing servers, with revenues of RMB 24.12 billion, RMB 26.78 billion, and RMB 37.34 billion from 2022 to 2024 [7]. - Changfeng Pharmaceutical Co., Ltd. focuses on inhalation technology, with projected revenues of RMB 3.49 billion, RMB 5.56 billion, and RMB 6.08 billion from 2022 to 2024 [8]. - Bokan Vision Cloud Pharmaceutical Co., Ltd. is a clinical-stage ophthalmic biotech company with projected revenues of approximately USD 10 million in 2024 [9]. - Shenzhen Huada Beidou Technology Co., Ltd. is a leading provider of space positioning services, with revenues of RMB 6.98 billion, RMB 6.45 billion, and RMB 8.40 billion from 2022 to 2024 [10]. - Suzhou Youlesai Shared Services Co., Ltd. is the second-largest provider of circular packaging services in China, with revenues of RMB 6.48 billion, RMB 7.94 billion, and RMB 8.38 billion from 2022 to 2024 [11]. - Xuan Bamboo Biotechnology Co., Ltd. is a biopharmaceutical company with over ten drug assets in development, reporting revenues of RMB 2.9 million and RMB 30.09 million for 2023 and 2024, respectively [12]. - Jinye International Group Co., Ltd. is an established contractor in electromechanical engineering, with projected revenues of approximately HKD 123 million and HKD 155 million for the 2023/24 and 2024/25 fiscal years [14]. Group 2: Companies Passing Hearings - Yaojie Ankang (Nanjing) Technology Co., Ltd. focuses on innovative therapies for tumors and metabolic diseases, currently without any approved products for commercial sale [15][16]. - Yingtong Holdings Limited is the largest perfume group in China by retail sales, with projected revenues of RMB 16.99 billion, RMB 18.64 billion, and RMB 20.83 billion from 2023 to 2025 [17]. - Saint Bella Limited is the largest comprehensive family care brand group in China, with revenues of RMB 4.72 billion, RMB 5.6 billion, and RMB 7.99 billion from 2022 to 2024 [18]. - Hubei Xiangjiang Electric Co., Ltd. is a manufacturer of household products, with revenues of RMB 10.97 billion, RMB 11.88 billion, and RMB 15.02 billion from 2022 to 2024 [19]. - Cao Cao Travel Co., Ltd. is a ride-hailing platform with a total transaction value of RMB 12.2 billion in 2023, expected to grow to RMB 17 billion in 2024 [20]. - Anjii Food Group Co., Ltd. is the largest frozen food company in China, with revenues of RMB 121.06 billion, RMB 139.65 billion, and RMB 150.30 billion from 2022 to 2024 [21]. - Cloud Wisdom Intelligent Technology Co., Ltd. is a leading AI solution provider in China, with revenues of RMB 6.01 billion, RMB 7.27 billion, and RMB 9.39 billion from 2022 to 2024 [22]. - IFBH Pte. Ltd. is a beverage company with a leading market share in coconut water in China, reporting revenues of USD 87.44 million and USD 158 million for 2023 and 2024, respectively [23]. Group 3: Companies Launching IPOs - Haitan Flavor Industry plans to issue 263 million H-shares, with a price range of HKD 35-36.3 per share, expected to start trading on June 19, 2025 [24]. - Sanhua Intelligent Control plans to issue 360 million H-shares, with a price range of HKD 21.21-22.53 per share, expected to start trading on June 23, 2025 [25]. - Baize Medical plans to issue 133 million shares, with a price range of HKD 4.22-6.75 per share, expected to start trading on June 23, 2025 [26]. - Yaojie Ankang-B plans to issue 15.28 million H-shares, with a price of HKD 13.15 per share, expected to start trading on June 23, 2025 [27]. Group 4: New Stocks Listed - METALIGHT listed on June 10, 2025, closing at HKD 6.80 per share, down 30.26% [28]. - Xinqianan listed on June 10, 2025, closing at HKD 22.95 per share, up 21.43% [29]. - Rongda Technology listed on June 10, 2025, closing at HKD 14.29 per share, up 42.00% [30].
一周港股IPO：银诺医药等11家公司递表，药捷安康等8家通过聆讯